HRK (NM_003806) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC212069L4V

  • LentiORF®

Lenti ORF particles, HRK (mGFP-tagged) - Human harakiri, BCL2 interacting protein (contains only BH3 domain) (HRK), 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP

Lentiviral Particles: DDK DDK w/ Puro mGFP mGFP w/ Puro

AAV Particle: DDK


Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50

USD 700.00

2 Weeks*

Size
    • 200 ul

Product Images

Frequently bought together (3)
Lenti ORF control particles of pLenti-C-mGFP-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

USD 365.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

USD 671.00


Rabbit Polyclonal Anti-HRK Antibody
    • 100 ul

USD 380.00

Specifications

Product Data
Type Human Tagged ORF Clone Lentiviral Particle
Tag mGFP
Symbol HRK
Synonyms DP5; HARAKIRI
Mammalian Cell Selection Puromycin
Vector pLenti-C-mGFP-P2A-Puro
ACCN NM_003806
ORF Size 273 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC212069).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_003806.1
RefSeq Size 716 bp
RefSeq ORF 276 bp
Locus ID 8739
UniProt ID O00198
Cytogenetics 12q24.22
Protein Families Druggable Genome, Transmembrane
MW 9.7 kDa
Gene Summary This gene encodes a member of the BCL-2 protein family. Members of this family are involved in activating or inhibiting apoptosis. The encoded protein localizes to intracellular membranes. This protein promotes apoptosis by interacting with the apoptotic inhibitors BCL-2 and BCL-X(L) via its BH3 domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.